Atlanta Cancer Care - Cumming — Cumming, Georgia

Atlanta Cancer Care - Cumming is a clinical research site located in Cumming, Georgia, United States 30041.

Crixeo Health Trust Score: 69/100 (FAIR). This profile has not yet been claimed by the site owner.

Atlanta Cancer Care - Cumming has participated in 6 clinical trials with 2 currently active.

Therapeutic areas: HER2-positive Breast Cancer, HER2 Positive Breast Cancer, Breast Neoplasms.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Gilead Sciences, Pfizer.

Sponsor Feasibility Report

Trust Score: 69/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Atlanta Cancer Care - Cumming?

Atlanta Cancer Care - Cumming has a Crixeo Trust Score of 69/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Atlanta Cancer Care - Cumming conducted?

Atlanta Cancer Care - Cumming has 6 clinical trials on record, with 2 currently active. Their work covers HER2-positive Breast Cancer, HER2 Positive Breast Cancer, Breast Neoplasms.

Is Atlanta Cancer Care - Cumming accredited by Crixeo Health?

Atlanta Cancer Care - Cumming has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Atlanta Cancer Care - Cumming?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.